Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Esophageal
Study Phase
Phase 3
Study Completion Date
April 2015
NCT00655876Uploaded 09-02-2020
Access via NCI by Request
PDS UID - nci-data-423
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
Files: NCT00655876-D1
Data DictionaryNCT00655876-D1-Data-Dictionary_1.pdf
DATANCT00655876-D1-Dataset.csv
OTHERREADME.pdf
Files: NCT00655876-D2
Data DictionaryNCT00655876-D2-Data-Dictionary_1.pdf
DATANCT00655876-D2-Dataset.csv
OTHERREADME.pdf